Chimerix Announces Fourth Quarter and Full Year 2018 Financial Results

NEXT STORY
BeyondSpring Presents New Promising Data in Chemotherapy-Induced Neutropenia at 2019 ASCO-SITC Clinical Immuno-Oncology Symposium
PREV STORY
Novartis Cosentyx® shows superior improvements in psoriasis patients’ quality of life versus Janssen’s IL-23 Stelara®*
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Precision Therapeutics Reports First Quarter 2018 Financial Results

MINNEAPOLIS, May 15, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ:AIPT) (“Precision” or “the ...

author_avatar
NASDAQ Market News

Genocea to Present at Stifel 2017 Healthcare Conference

CAMBRIDGE, Mass., Nov. 08, 2017 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ:GNCA), a biopharmaceutical company ...

author_avatar
NASDAQ Market News

ASLAN Pharmaceuticals Prices Initial Public Offering of Its American Depositary Shares

SINGAPORE, May 04, 2018 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals Limited (TPEx:6497.TT), a clinical-stage biopharmaceutical ...

author_avatar
NASDAQ Market News